AI brief of an SEC Form 8-K · ASPEN AEROGELS INC (ASPN)

Aspen Aerogels Q3 revenue rises to $85.2 million; net loss widens to $10.4 million

Mixed Impact 3 of 5 earnings Written later

Aspen Aerogels reported third quarter 2026 revenue of $85.2 million, up from $73.0 million a year earlier, but its net loss widened to $10.4 million from $6.3 million, including $15.1 million of East Providence incident-related costs. The company's fourth quarter 2026 outlook calls for revenue of $60 million to $75 million and a net loss of $8 million to $11 million, and it also appointed Stacy D. Nieuwoudt to its board.

Key points

  • Q3 2026 revenue was $85.2 million versus $73.0 million in Q3 2025; Energy Industrial segment revenue was $39.9 million versus $24.3 million.
  • Q3 2026 net loss was $10.4 million, or $0.13 per share, versus $6.3 million, or $0.08 per share, a year earlier.
  • Q4 2026 outlook: revenue of $60 million to $75 million, net loss of $8 million to $11 million, and adjusted EBITDA of $5 million to $13 million.
  • Stacy D. Nieuwoudt joined the board effective November 4, 2026, increasing the board from six to seven members.

The filing

CompanyASPEN AEROGELS INC (ASPN)
Form8-K, current report
Filed with the SECNov 5, 2026, 6:30 AM ET
Accession number0001171843-26-007142

Items reported: 2.02 Results of Operations5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.